The General Meeting is the highest decision-making body of Bioretec and is convened by the Board of Directors. The shareholders take part in the company's governance and administration through decisions made in the General Meetings of shareholders. Pursuant to the Finnish Limited Liability Companies Act, the Annual General Meeting shall be held annually on a date set by the Board of Directors within six (6) months of the end of the company's financial period.
An Extraordinary General Meeting shall be convened to address certain matters, when the Board of Directors considers it necessary or when the company's auditor or shareholders representing at least one-tenth of all of the issued and outstanding shares in the company request that in writing.
The Annual General Meeting decides on matters that fall under the Companies Act and the Articles of Association, such as:
Pursuant to Bioretec's Articles of Association, the notice of General Meeting of shareholders shall be delivered no earlier than one month and no later than one week before the record date for the General Meeting, of shareholders and always no later than one week before the last date for advance notices of participation, by publishing it on the company's website or by providing the notice to each shareholder by letter or email at the addresses entered into the shareholder register.
In order to participate in the General Meeting of shareholders, a shareholder must give advance notice of participation to the company no later than the date given in the notice of the General Meeting of shareholders, which shall not be earlier than ten (10) days before the meeting. In accordance with the Nasdaq First North Growth Market Rulebook, Bioretec shall also publish the notice of General Meeting of shareholders as a company release.
Notice to extraordinary General Meeting
EGM minutes
Resolutions of the Extraordinary General Meeting
Proxy template
Privacy policy
Registration and advance voting form
Report on events having essential effect on the state of the company occurred after the preparation of the latest financial statements
Financial statements bulletin 2025
Financial statements bulletin 2024
Financial statements 2025
Financial statements 2024
Decisions regarding distributions of funds
AGM minutes (in Finnish)
Resolutions of the General meeting
Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors
Proxy template
Registration and voting form
General Meeting notice
Privacy Policy
Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026
Financial Statements 2025
Annual Report 2025
Notice to AGM
AGM agenda
Proposal for a new board member
Financial statements 2021
Proxy template (AGM notice - appendix 1)
Terms of the option program 2020-1 (AGM notice – appendix 2)
Resolutions of Bioretec Ltd´s Annual General Meeting and the organizing meeting of the Board of Directors (Apr 13, 2022)
AGM Meeting Minutes (Apr 13, 2022 fi/en)